HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In-Su Kim Selected Research

1-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)

4/2022Dioscin-Mediated Autophagy Alleviates MPP+-Induced Neuronal Degeneration: An In Vitro Parkinson's Disease Model.
10/2020GPR4 Knockout Improves the Neurotoxin-Induced, Caspase-Dependent Mitochondrial Apoptosis of the Dopaminergic Neuronal Cell.
2/2017Analysis of Epidermal Growth Factor Receptor Related Gene Expression Changes in a Cellular and Animal Model of Parkinson's Disease.
1/2013Gastrodin protects apoptotic dopaminergic neurons in a toxin-induced Parkinson's disease model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


In-Su Kim Research Topics

Disease

13Parkinson Disease (Parkinson's Disease)
04/2022 - 04/2011
12Neuroinflammatory Diseases
01/2022 - 01/2012
8Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 01/2018
6Cognitive Dysfunction
05/2021 - 01/2012
6Inflammation (Inflammations)
01/2021 - 08/2012
5Insulin Resistance
01/2014 - 01/2010
4Neuroblastoma
04/2022 - 11/2016
4Nervous System Diseases (Neurological Disorders)
01/2022 - 01/2018
3Type 2 Diabetes Mellitus (MODY)
08/2012 - 01/2011
2B-Cell Lymphoma (Lymphoma, B Cell)
04/2022 - 10/2020
2Epilepsy (Aura)
01/2022 - 01/2019
2Mitochondrial Diseases (Mitochondrial Disease)
01/2022 - 01/2021
2Neoplasms (Cancer)
12/2020 - 01/2020
2Wounds and Injuries (Trauma)
01/2019 - 01/2018
2Gliosis
08/2013 - 01/2013
2Carcinoma (Carcinomatosis)
08/2012 - 01/2010
2Diabetes Mellitus
08/2012 - 01/2010
1Alzheimer Disease (Alzheimer's Disease)
01/2022
1Amnesia (Dissociative Amnesia)
05/2021
1Genomic Instability
01/2021
1Hypersensitivity (Allergy)
12/2020
1Stroke (Strokes)
01/2019
1Diabetic Neuropathies (Diabetic Neuropathy)
01/2019
1Infections
01/2018
1Brain Diseases (Brain Disorder)
01/2018
1Cicatrix (Scar)
01/2017
1Central Nervous System Diseases (CNS Diseases)
10/2015
1Hypoxia (Hypoxemia)
06/2015
1Pain (Aches)
04/2015
1Carotid Artery Injuries
12/2014
1Chronic Disease (Chronic Diseases)
01/2014
1Hyperglycemia
01/2014
1Hypokinesia (Bradykinesia)
01/2013
1Atherosclerosis
02/2012

Drug/Important Bio-Agent (IBA)

51- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
04/2021 - 01/2013
5CytokinesIBA
01/2021 - 01/2012
5Glucose (Dextrose)FDA LinkGeneric
01/2014 - 01/2010
41-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)IBA
04/2022 - 01/2013
4Proteins (Proteins, Gene)FDA Link
01/2022 - 11/2016
4asaroneIBA
01/2022 - 01/2012
4Biological ProductsIBA
01/2021 - 01/2014
3Neuroprotective AgentsIBA
01/2022 - 01/2013
3Pharmaceutical PreparationsIBA
01/2022 - 01/2018
3AntioxidantsIBA
12/2020 - 01/2012
3NF-kappa B (NF-kB)IBA
01/2017 - 01/2012
3Insulin (Novolin)FDA Link
08/2012 - 01/2010
2LipopolysaccharidesIBA
05/2021 - 04/2011
2Scopolamine (Hyoscine)FDA Link
05/2021 - 01/2018
2ErbB Receptors (EGF Receptor)IBA
01/2020 - 02/2017
2Cholinergic Agents (Cholinergics)IBA
01/2018 - 01/2012
2Transcription Factors (Transcription Factor)IBA
06/2015 - 12/2012
1Caspase 3 (Caspase-3)IBA
04/2022
1dioscinIBA
04/2022
1Nerve Growth Factors (Neurotrophins)IBA
01/2022
1SynucleinsIBA
01/2022
1CaspasesIBA
04/2021
14-trifluoromethylsalicylic acid (HTB)IBA
11/2020
1AnhydridesIBA
11/2020
1bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA
10/2020
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
10/2020
1Messenger RNA (mRNA)IBA
10/2020
1trisialoganglioside GT1IBA
01/2020
1InflammasomesIBA
01/2020
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2020
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
10/2019
1GTP-Binding Proteins (G-Protein)IBA
10/2019
1QuercetinIBA
10/2019
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2019
1TaurineFDA Link
01/2019
1PolyphenolsIBA
01/2019
1Liposomes (Liposome)IBA
09/2018
1ginsenoside M1IBA
09/2018
1gintoninIBA
09/2018
1GinsenosidesIBA
09/2018
1Coloring Agents (Dyes)IBA
01/2018
1thymoquinoneIBA
01/2018
1Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2018
1Glutamate Receptors (Glutamate Receptor)IBA
01/2018
1Retinaldehyde (Retinal)IBA
01/2017
1Connexin 43 (Connexin43)IBA
11/2016
1ConnexinsIBA
11/2016
1Small Interfering RNA (siRNA)IBA
11/2016
1Therapeutic UsesIBA
10/2015
1Oxygen (Dioxygen)IBA
06/2015
1Ethanol (Ethyl Alcohol)IBA
04/2015
1CollagenIBA
12/2014
1Adenosine Diphosphate (ADP)IBA
12/2014
1Blood Glucose (Blood Sugar)IBA
01/2014
1NeurotoxinsIBA
08/2013
1Dopamine (Intropin)FDA LinkGeneric
01/2013
1gastrodinIBA
01/2013
1PyrrolidinesIBA
01/2013
1Hypoglycemic Agents (Hypoglycemics)IBA
08/2012
1eriodictyolIBA
08/2012
1Becaplermin (PDGF-BB)FDA Link
02/2012
1naringeninIBA
02/2012

Therapy/Procedure

5Therapeutics
04/2022 - 01/2017
2Oral Administration
11/2020 - 12/2014
2East Asian Traditional Medicine (Oriental Medicine)
04/2015 - 11/2013
1Lasers (Laser)
01/2017